Buscar
01/01/2022
Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery
Mateu-Arrom, L, Gutierrez-Ruiz, C, Rubio, LS, Barea, VM, Redorta, JP, Errando-Smet, C. Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery. Actas Urologicas Espanolas. 2022; 46(1)DOI:10.1016/j.acuro.2020.11.013. PMID:34462149. IF:1.100(Q4/9D).
01/01/2022
Perioperative and Functional Outcomes of Robot-assisted Ureteroenteric Reimplantation: A Multicenter Study of Seven Referral Institutions
Carrion, A, Hussein, AA, Eun, D, Hosseini, A, Gaya, JM, Abaza, R, Bonet, X, Iqbal, U, Lee, RA, Lee, Z, Lee, M, Raventos, C, Moreno, O, Palou, J, Breda, A, Lozano, F, Vigues, F, Trilla, E, Guru, KA. Perioperative and Functional Outcomes of Robot-assisted Ureteroenteric Reimplantation: A Multicenter Study of Seven Referral Institutions. European Urology Open Science. 2022; 35DOI:10.1016/j.euros.2021.11.005. PMID:35024631. IF:2.500(Q3/6D).
01/01/2022
Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter
Kamat, AM, Lobo, N, Lerner, SP, Li, R, Matulay, JT, Palou, J, Witjes, JA, Roupret, M, Smith, AB, Chang, SS, Shore, ND, Steinberg, GD, Dinney, CP, Svatek, RS, Lamm, DL. Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter. Bladder Cancer. 2022; 8(2)DOI:10.3233/BLC-211648. PMID:. IF:1.100(Q4/9D).
01/01/2022
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models
Guerrero-Ramos, F, Subiela, JD, Rodriguez-Faba, O, Aumatell, J, Manfredi, C, Bozzini, G, Romero-Otero, J, Counago, F. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models. Bladder Cancer. 2022; 8(4)DOI:10.3233/BLC-220055. PMID:. IF:1.100(Q4/9D).